©2022 Stanford Medicine
Identification of Key Blood Molecular Markers for Immunotherapy
Not Recruiting
Trial ID: NCT00507702
Purpose
To identify unique blood markers in cancer patients so that we can identify patients with
evidence of pre-existing immunity who may be a responder to immunotherapy.
Official Title
Identification of Key Blood Molecular Markers for Immunotherapy
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
1. Patients diagnosed with cancerous tumors based on biopsy or other clinical
observations.
2. Patients diagnosed with non-cancerous tumors based on biopsy or other clinical
observations.
3. Normal volunteers who do not have cancer or other medical conditions that may affect
survival.
Exclusion Criteria:
1. Patients will be excluded if, upon clinical observation, they are under a severe
septic or inflammatory condition. In these conditions, human body immune response
against sepsis or inflammation should be the predominant response, and may shield or
block the immune response against tumors.
2. Patients will be excluded if, upon clinical observation, they are under extremely
illness situation like myocardial infarction. In such a case, the immune findings may
be altered.
3. Patients will be excluded if, upon looking through their medical records, significant
information required for data analysis is missing. This is because that patients'
medical records will help us connect our research findings with their clinical
observations, and further provide guidelines for subsequent treatment options.
Intervention(s):
procedure: phlebotomy
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Kangla Tsung
650-725-8198